SUPERNUS PHARMACEUTICALS, INC. reports

Company location: Rockville, MD
Fiscal year end: 31 December

SUPERNUS PHARMACEUTICALS, INC. has filed 1,156 SEC EDGAR filings since 06 Mar 2006

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page

25

Current page

7

4

FORM 4

Filing date: 03 Apr 2025
Reporting date: 02 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Mar 2025
Reporting date: 10 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Mar 2025
Reporting date: 10 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 Mar 2025
Reporting date: 07 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 Mar 2025
Reporting date: 07 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Mar 2025
Reporting date: 05 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Mar 2025
Reporting date: 05 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Mar 2025
Reporting date: 05 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Mar 2025
Reporting date: 05 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Mar 2025
Reporting date: 28 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Mar 2025
Reporting date: 28 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 26 Feb 2025
Reporting date: 26 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-35518

10-K

Filing date: 25 Feb 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35518

8-K

Filing date: 25 Feb 2025
Reporting date: 25 Feb 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 21 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 21 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 21 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 22 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 22 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 22 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 22 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 22 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Feb 2025
Reporting date: 22 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 POS File 333-181479

FORM S-8 POS

Filing date: 24 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35518

8-K

Filing date: 24 Feb 2025
Reporting date: 24 Feb 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .